nitroxyl and cardiovascular agents

nitroxyl has been researched along with cardiovascular agents in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Alexander, AE; Cao, N; Gossain, S; Horowitz, JD; Irvine, JC; Kemp-Harper, BK; Love, JE; Qin, C; Ritchie, RH	1
Horowitz, JD; Kemp-Harper, BK; Ritchie, RH	1
Bian, JS; Cao, L; Huang, DJ; Nie, XW; Sun, HJ; Sun, MT; Wu, ZY; Zhu, MY	1
Kemp-Harper, B	1

Reviews

3 review(s) available for nitroxyl and cardiovascular agents

Article	Year
Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure. Drugs, 2016, Volume: 76, Issue:14 Topics: Animals; Cardiovascular Agents; Clinical Trials as Topic; Heart Failure; Humans; Nitric Oxide; Nitrogen Oxides; Oxidation-Reduction	2016
Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology. Pharmacological research, 2020, Volume: 159 Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Humans; Hydrogen Sulfide; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides	2020
Vasoprotective Actions of Nitroxyl (HNO): A Story of Sibling Rivalry. Journal of cardiovascular pharmacology, 2021, 12-01, Volume: 78, Issue:Suppl 6 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiovascular Agents; Cardiovascular Diseases; Endothelial Cells; Endothelium, Vascular; Humans; Nitrogen Oxides; Platelet Aggregation Inhibitors; Signal Transduction; Vasodilator Agents	2021

Other Studies

1 other study(ies) available for nitroxyl and cardiovascular agents

Article	Year
HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO. American journal of physiology. Heart and circulatory physiology, 2013, Aug-01, Volume: 305, Issue:3 Topics: Animals; Animals, Newborn; Antioxidants; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Inhibitors; Gene Expression Regulation; Guanylate Cyclase; Hydrazines; Myocytes, Cardiac; Nitric Oxide Donors; Nitrogen Oxides; Pyrogallol; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Second Messenger Systems; Soluble Guanylyl Cyclase; Time Factors	2013

Article

Year

HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO.

American journal of physiology. Heart and circulatory physiology, 2013, Aug-01, Volume: 305, Issue:3

Topics: Animals; Animals, Newborn; Antioxidants; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Inhibitors; Gene Expression Regulation; Guanylate Cyclase; Hydrazines; Myocytes, Cardiac; Nitric Oxide Donors; Nitrogen Oxides; Pyrogallol; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Second Messenger Systems; Soluble Guanylyl Cyclase; Time Factors

2013